Siemens demonstrated hands-off imaging at the RSNA with a work in progress that turns control of an MR scanner over to remote operators. The goal behind Expert-I, which is pending FDA clearance, is to allow expert collaboration on challenging examinations regardless of how far away the expert may be.
Siemens demonstrated hands-off imaging at the RSNA with a work in progress that turns control of an MR scanner over to remote operators. The goal behind Expert-I, which is pending FDA clearance, is to allow expert collaboration on challenging examinations regardless of how far away the expert may be.
With the necessary software and a high-speed connection, experts can work an MR console from their PCs while patients are being scanned, according to the company. Patient set-up, sequences, and imaging data can be viewed in real-time.
Siemens demonstrated the capability in its exhibit booth utilizing a real-time link between the University of California-Los Angeles and Northwestern University in Chicago.
Other Siemens MR introductions include syngo Susceptibility Weighted Imaging (SWI), which promises to better visualize bleeding in stroke and brain trauma patients, contusions and shearing injuries, and minute intracranial vascular malformations. A body diffusion technique, called syngo REVEAL, helps differentiate lesions throughout the body, particularly malignant from benign ones. Syngo GRAPPA offers faster spine and cardiac imaging, with a small field-of-view to provide high spatial resolution.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
Breast MRI and Dense Breasts: A Closer Look at Early Findings from a New Prospective Trial
May 2nd 2024Supplemental breast MRI had a cancer detection rate (CDR) of 20/1000 and a positive predictive value (PPV) of 50 percent, according to preliminary findings from a prospective trial involving women with heterogeneously or very dense breasts.